Germany Veterinary Healthcare Market 2014-2019

GERMANYVETERINARY HEALTHCARE MARKET

Market Shares, Forecasts& Trends

2014 - 2019

mordorintelligence.com

Germany Veterinary Healthcare Market | Sample

RESEARCH METHODOLOGY

1) Secondary Research: Information was collected from a number of public and paid data sources.

Public sources involved Government websites, publications from the Animal healthcare

programs of different countries, company annual reports, white papers and research

publications by recognized industry experts. Paid data sources include authentic industry

databases.

2) Primary Research: After collecting data from secondary sources, primary interviews were

conducted with stakeholders at different points of the animal healthcare products

manufacturers, distributors, ingredient suppliers, companies producing veterinary products and

key opinion leaders of the industry. Primary research is used both to validate the data points

obtained from secondary research and to fill any gaps in data.

3) Market Analysis: The market analysis phase involves analyzing the collected data, market

breakdowns and forecasting. Macroeconomic indicators and bottom-up and top-down

approaches are used to arrive at a complete set of data points that give way to valuable

qualitative and quantitative insights. Each data point is verified by the process of data

triangulation to validate the numbers and arrive at a close estimate.

4) Expert Validation: The market analysis data is verified and validated by a number of experts,

both in-house and external.

5) Report Writing: After the data is curated through the process, our analysts begin to write the

report. Garnering insights from data and forecasts, insights are drawn to visualize the entire

business ecosystem in a single report.

gtjg

Typewriter

VIEW THIS REPORT ON OUR WEBSITE

http://mordorintelligence.com/?s=Veterinary+Healthcare+Market&post_type=product&utm_source=tumblr&utm_medium=banner&utm_campaign=tu-fullveternary


TABLE OF CONTENTS

1. INTRODUCTION 1

1.1. Methodology 1

1.2. Definition of the market 2

2. KEY FINDINGS OF THE STUDY 3

3 Germany Veterinary Healthcare Market – Overview 4

4. GLOBAL MARKET ANALYSIS 5

4.1. Livestock Industry Trend 5

4.2 Farm animals Health Trend 7

4.3 Companion animals health trend 8

4.4. Threshold matters of the Industry 9

4.5. Factors Affecting the Global Market 10

4.5.1. Drivers 10

4.5.2. Restraints 17

4.5.3. Opportunities 22

4.6. Porters Analysis 23

4.6.1. Bargaining power of Buyers 24

4.6.2. Bargaining power of Suppliers 25

4.6.3. Degree of Competition 26

4.6.4. Threat of new entrants 27

4.6.5. Threat of Substitutes 28

4.7. Global Regulatory Environment-Impact Analysis 29

4.8. Value Chain Analysis

gtjg

Typewriter




5.Germany’s Share in the Europe Veterinary health care market. 30

6. Germany’s Animal Veterinary care market- Market Segmentation by products 31

6.1 Vaccines 33

6.2 Anti-Infectives 35

6.3 Paraciticides 39

6.4 Medicinal Feed Additives 42

6.5 Other Phamaceuticals 44

7. Germany’s Veterinary health care market- Market Segmentation by Animals 45

7.1 Farm animal health market 45

7.1.1 Poultry health market 46

7.1.2 Swine health market 48

7.1.3 Fish health market 50

7.1.4 Cattle health market 52

7.1.5 Sheep health market 54

7.2 Companion animal health market 55

7.2.1 Dogs and Cats Market 57

7.2.2 Horse health market 59

8. The future of the industry-Expert View 60

9. Key players’ profile – Global 61

9.1 Zoetis Animal Healthcare 62

9.2 Merck Ltd. 64

9.3 Merial( Animal Health division of Sanofi) 66

9.4 Elanco Animal Health 67

gtjg

Typewriter




69 9.5 Bayer Animal Health

9.6 Novartis Animal Health.

9.10 BOEHRINGER INGELHEIM

70

10. Appendix 72

10.1.Abbreviations 73

10.2.Sources 74

10.3.Bibliography 76

10.4.Disclaimer 77

71

gtjg

Typewriter



Germany Veterinary Healthcare Market | Sample 2 | Mordor Intelligence

MARKET DEFINITION

Animal health market is a growing industry comprising companion animals and Farm animals.

Companion animals are those which people tame or adopt for companionship, house/ office guards,

and farm animals are raised for meat and milk related products. Companion animals include dogs, cats

and horses. Farm animals are Cattle, Poultry, Swine, Fish, etc.

Major companies in the market are actively producing and manufacturing animal health care products,

pharmaceuticals and others. This market research report provides in-depth market intelligence of

animal health care industry.

Germany veterinary healthcare market is growing because of the increasing population of both the

types of animals. Increasing consumption of meat and milk products, new diseases in animals and

transfer of these diseases from animals to human beings are propelling animal healthcare market

globally.

The changing lifestyle, increasing per capita income and increasing population has led to an increase in

meat consumption. The demand of animal rich protein such as meat, eggs and milk is rising and due to

this, population of farm animals is also increasing.

Based on the products, market is divided into vaccines, paraciticides, anti-infectives and medicinal feed

additives. Medicinal feed additives are growing at a faster pace because of people’s awareness of

animal health and the connection between animal health and human health. The pharmaceutical and

vaccine market is growing due to increasing number of diseases in animal and increasing concern of

animal immunization.

gtjg

Typewriter

VIEW THIS REPORT ON THE WEBSITE


GERMANY VETERINARY HEALTHCARE MARKET

Germany veterinary market is a relatively small market. About 10 MNCs and 20 medium-sized local

manufacturers of veterinary medicine are competing in this market. The market is continuously growing

for the last 10 years, however, mostly in moderate percentages.

There are approximately 13.7 million heads of cattle; 26.2 millions of pigs; 2.1 millions of sheep, 446

million units for chicken raising and 48 millions of hens. About 4.000 pet consultancies attend 4.7

million dogs; 7 million cats and about 1 million horses. German veterinary healthcare market consists of

vaccines, paraciticides, anti-infectives, medicinal feed additives and other pharmaceuticals. There are

around 30 additional medium sized German companies which are working in other areas of animal

health for e.g. veterinarian diagnostics, surgical instruments, animal care products and their sales. Their

sales value estimated in Germany is about 240 million Euros per year.

German veterinary healthcare market is US $1.01 billion in 2014 and is estimated to reach US$1.62

billion by 2019 at a CAGR of 9.91%. This market is in a process of strong diversification. Within this

market, functional products which support defined physiological needs of the animals and the Life-

Cycle-Products which respond to special nutritional needs of pets are gaining the customer’s

acceptance.

Source: Mordor Intelligence Analysis

0

0.5

1

1.5

2

2011 2012 2013 2014 2019

$ bi

llion

Germany Veterinary Healthcare Market

gtjg

Typewriter




MARKET DRIVERS

GREATER LIVESTOCK PRODUCTION

The demand for information on livestock production is growing, both in the sense of demands

expressed by the producers themselves, and in the more general sense of a growing potential for

increasing production through the delivery of information. The livestock sector is very dynamic globally.

Rapidly increasing demand for livestock products in developing countries is the major factor for

increased livestock production. In developed countries, demand for livestock products is stagnating,

while many production systems are increasing their efficiency and environmental sustainability.

Developments in breeding, nutrition and animal health will continue to contribute to increasing

population of livestock. Demand for livestock products in the future could be heavily moderated by

socio-economic factors such as human health concerns and changing socio-cultural values. The global

livestock sector is characterized by a dichotomy between developing and developed countries. Total

meat production in the developing world tripled between 1980 and 2002, from 45 to 134 million tons

(World Bank 2009). Every year the number of farms and heads of animals are increasing in Germany. In

2010, the number of farms and heads of animals were approximately 216,100 and this number is

estimated to increase in the coming years owing to increasing demand of livestock population in this

region.

gtjg

Typewriter




GERMANY FARM AND COMPANION VETERINARY HEALTH MARKET

Livestock is the main source of income in agriculture. Approx. 60 percent of the revenue from German

agriculture comes from the sale of livestock farming products.

Pigs

In May 2009, roughly 26.9 million pigs were kept in approx. 67,600 farms in Germany. This implies the

number of pigs has increased by 0.6 percent as compared to the previous year and the number is

expected to increase in forecast period 2014-2019. There was a slight rise in the number of breeding

cows of 0.5 percent to 2.3 million in the last six months. With a share of almost 20 percent, Germany is

the largest pork producer in the EU and with 15 percent, the second largest producer of beef and veal.

Talking about companion animal market in Germany, there are 8 million cats, over 5 million dogs and

another 5 million small animals.

Both companion and Farm animal market consists of vaccines, paraciticides, anti-infectives, medicinal

feed additives etc. Animal vaccines is the fastest growing market estimated to reach US$ 0.925 billion in

2019 with a healthy CAGR of 10.28% , followed by Anti-infectives market growing at a CAGR of 9.54%.

Germany Farm animal health market is US$ 0.369 in 2014 and is estimated to reach US$ 0.587 by 2019.


0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

2011 2012 2013 2014 2019

$ bi

llion

Germany Farm Animal Healthcare Market

DATA HIDDEN FROM VIEW

gtjg

Typewriter






0

0.2

0.4

0.6

0.8

1

1.2

2011 2012 2013 2014 2019

$ bi

llion

Germany Comapnion Animal Healthcare Market

Germany Veterinary Healthcare Market Share

Anit-Infectives

DATA HIDDEN FROM VIEW

gtjg

Typewriter




COMPANY PROFILES

BAYER ANIMAL HEALTH

BUSINESS OVERVIEW

Bayer HealthCare Animal Health is one of the world’s leading research-based veterinary medicine

companies. We rank among the top five animal health companies in the world, and are a global leader in

parasiticides and companion animal products.

Bayer HealthCare's Animal Health Division is the maker of Advantage Multi (imidacloprid + moxidectin)

Topical Solution for dogs and cats, Advantage flea control for cats and dogs and K9 Advantix, a flea,

tick, and mosquito control product for dogs. Advantage Multi, K9 Advantix and Advantage are

trademarks of Bayer. The division specializes in parasite control and prescription pharmaceuticals for

dogs, cats, horses, and cattle. North American operation for the Animal Health Division is headquartered

in Shawnee, Kansas. Bayer Animal Health is a division of Bayer HealthCare LLC, one of the world's

leading healthcare companies.

FINANCIAL OVERVIEW

Bayer HealthCare’s Animal Health Divison generated a revenue of about $1.716 billion for the year 2013.

There revenue increased by 0.2% compared to that of the year 2012 where the revenue generated was

$1.712 billion.

PRODUCTS

Advantage® II controls against all flea life stages. Kills through contact. Fleas don't have to bite

to die. Advantage® II is a convenient monthly topical application that is for use on dogs and

puppies 7 weeks of age and older, weighing 3 lbs or more.

Advantage® Treatment Shampoo for dogs & puppiesto kill fleas and ticks on contact. For use on

dogs and puppies over 12 weeks.

gtjg

Typewriter


http://www.petparents.com/show.aspx/products/advantage-ii-for-dogs



Seresto®, the performance you expect from a topical in an easy-to-use collar with sustained

release technology that offers 8 months of continuous protection against fleas and ticks. For

use on dogs and puppies 7 weeks of age and older.

K9 Advantix® II offers broad spectrum protection against fleas, ticks and mosquitoes, too. It is

specifically formulated for dogs and comes in a convenient, monthly topical application that not

only kills but also repels fleas, ticks and mosquitoes. K9 Advantix®IIalso kills ALL life stages of

fleas, repels biting flies and kills lice. K9 Advantix® II is for use on dogs 7 weeks and older and

weighing 4 lbs. or more.

K9 Advantix® II is for use on dogs only.

Seresto®, the performance you expect from a topical in an easy-to-use collar with sustained

release technology that offers 8 months of continuous protection against fleas and ticks. For

use on cats and kittens 10 weeks of age and older.

Advantage Multi® for Cats (imidacloprid+moxidectin), your convenient solution for broad

spectrum parasite protection. It kills adult fleas, treats flea infestations, treats and controls

common intestinal parasites (hookworms and roundworms) and ear mites, as well as prevents

heartworm disease. For use on cats and kittens at least 9 weeks of age and weighing at least 2

lbs.

gtjg

Typewriter




BOEHRINGER INGELHEIM

BUSINESS OVERVIEW

The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-

1939) in Ingelheim am Rhein. From its beginnings in 1885 when it employed just 28 people in Nieder-

Ingelheim, the company has since become a global enterprise.

As part of research and development activities for innovative drugs, the company focuses primarily on

the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous

system, metabolic diseases, virological diseases and oncology.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies.

Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400

employees. Since it was founded in 1885, the family-owned company has been committed to

researching, developing, manufacturing and marketing novel medications of high therapeutic value for

human and veterinary medicine.

FINANCIAL OVERVIEW

The revenue generated by the animal health division at Boehringer for the year is $1.479 billion. The

company observed a net revenue increase of 9.47% compared to the revenue generated in the year

2012. The revenue generated for the year 2012 was $1.351 billion.

PRODUCTS

Enterisol® Ileitis: For active immunisation of pigs against ileitis due to Lawsonia intracellularis

infection.

Ingelvac® Aujeszky MLV: Ingelvac® Aujeszky MLV is a gE®-deleted vaccine based on the

Bartha K61 strain which is licensed for active immunisation and eradication of Pseudorabies

virus in swine production units.

gtjg

Typewriter




Ingelvac CircoFLEX®: Ingelvac CircoFLEX® is a pig vaccine registered for use as a single

vaccination around weaning against the diseases associated with the porcine circovirus type-2

(PCV2). This includes the reduction of disease related clinical signs like mortality, weight loss

and lesions in the lymphoid tissue.

Metacam®: For use in non-infectious locomotor disorders to reduce the symptoms of lameness

and inflammation. For adjunctive therapy in the treatment of puerperal septicaemia and

toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy. For the

relief of post operative pain associated with minor soft tissue surgery such as castration.

Benestermycin® / Mamyzin® / A Mamyzin® Secado / Umpimycin®: For the treatment of

subclinical infections present at drying off and assistance in preventing new infections as well

as acute clinical mastitis during the dry period in dairy cattle.

gtjg

Typewriter




DISCLAIMER

Mordor Intelligence Reports and their contents, including all the analysis and research containing

valuable market information, are provided to a select group of customers in response to orders. Our

customers acknowledge when ordering that Mordor Intelligence strategic analysis services are for our

customers’ internal use and not for general publication or disclosure to third parties.

Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation.

Mordor Intelligence takes no responsibility for any incorrect information supplied to us by

manufacturers or users.

No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers

without written permission. Reproduction and/or transmission in any form and by any means including

photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is

prohibited.

ABOUT US

Mordor Intelligence is a global market research and consulting firm. Our singular focus is to provide

research insights for business success.

Our research team has expertise in diverse fields like Agriculture, Healthcare, ICT, Chemicals,

Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise maybe, everyone

in our team shares one common trait - we love data and we love providing solutions to clients using that

data even more. Seeing your business flourish based on our solutions and strategy is what we love the

most.

For information regarding permissions and sales, please contact: [email protected]

gtjg

Typewriter



7 | Mordor Intelligence !

!

Mordor Intelligence LLP No. 30, Padma Nilaya, Chola Nagar Bangalore, Karnataka, India 560032

+1 781 881 1110 | [email protected]

Copyright © 2014 Mordor Intelligence LLP All Rights Reserved. This document contains highly confidential information and is the sole property of Mordor Intelligence LLP. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of Mordor Intelligence LLP.

Documents

Germany Veterinary Healthcare Market 2014-2019